Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 420.70
-6.10 (-1.43%)
At close: Mar 23, 2026
Coloplast Market Cap
Coloplast has a market cap or net worth of 94.73 billion as of March 23, 2026. Its market cap has decreased by -45.34% in one year.
Market Cap
94.73B
Enterprise Value
118.70B
Revenue
27.89B
Ranking
n/a
PE Ratio
23.77
Stock Price
420.70
Market Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 5.88B to 94.73B, an increase of 1,511.01%. That is a compound annual growth rate of 10.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 94.73B | -23.07% |
| Dec 30, 2025 | 123.14B | -30.43% |
| Dec 30, 2024 | 177.00B | 2.05% |
| Dec 29, 2023 | 173.44B | 0.54% |
| Dec 30, 2022 | 172.51B | -29.57% |
| Dec 30, 2021 | 244.93B | 23.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.04T |
| Genmab | 101.63B |
| ALK-Abelló | 44.62B |
| Demant | 38.28B |
| H. Lundbeck | 36.28B |
| Zealand Pharma | 19.74B |
| Ambu A/S | 17.93B |
| Bavarian Nordic | 14.74B |